United States

Life sciences and the IPO journey


Life sciences organizations are going public in 2021 with biotech companies leading the pack as the dominant sector within the industry for new market entrants. By midyear, biotech has made up roughly 70% of all life sciences initial public offerings and capital raised, according to Bloomberg analysis.

Chris Martin, technical accounting consulting lead for RSM’s life sciences practice, discusses what’s driving this IPO trend in this brief video with Informa Connect. In addition, Chris shares what life sciences companies should do to prepare for an IPO now. According to him, people, processes, systems and controls are all part of the successful IPO equation, but there’s more to address, too. Watch and learn.

You may also be interested in

IPO readiness: 5 questions life sciences companies should consider

How can life sciences companies looking to go public position themselves for success? It’s all about setting the stage early on.

Is a SPAC the right route for your organization?

SPACs have grown in popularity recently as a means of going public. Learn why Draft Kings decided on a SPAC merger.

Subscribe to Life Sciences newsletter